Nonetheless, the potential for false-positive (1,3)-β-D-glucan results remains a possibility, particularly in patients receiving albumin—a common intervention in cirrhosis—which is known to elevate BDG levels [34]. This evidence concerns the gene ALB and Cirrhosis.